©The Author(s) 2025.
World J Gastroenterol. Oct 28, 2025; 31(40): 111499
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111499
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111499
Table 1 Take-home messages for practicing endoscopists based on current guidelines
| Society | Current position on AI in colonoscopy |
| ESGE[16] | Supports CADe use to reduce AMR, provided minimal false positives and no WT prolongation; allows CADx for “leave-in-situ”/“resect and discard”, if accuracy is equivalent to experts. Recommends AI integration to help standardize performance in less experienced endoscopists |
| BMJ[17] | Recommends against routine CADe use due to concerns over overdiagnosis, minimal clinical benefit, and increased surveillance; recommendation graded as “weak” |
| AGA[19] | Does not issue a definitive recommendation for or against CADe use, citing uncertainty in long-term outcomes |
| WEO[20] | Acknowledges CADe/CADx potential but urges cost-effectiveness assessment; highlights the need for high-quality real-world studies across healthcare systems |
- Citation: Dimopoulou K, Spinou M, Ioannou A, Nakou E, Zormpas P, Tribonias G. Artificial intelligence in colonoscopy: Enhancing quality indicators for optimal patient outcomes. World J Gastroenterol 2025; 31(40): 111499
- URL: https://www.wjgnet.com/1007-9327/full/v31/i40/111499.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i40.111499